Evidence map›Paper›PMID 37379528›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023

EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry.

Boris Schmidt, Stefano Bordignon, Kars Neven, Tobias Reichlin, Yuri Blaauw, Jim Hansen, Raquel Adelino, Alexandre Ouss, Anna Füting, Laurent Roten and 10 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 184 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 8 pooled it
56.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06765356 phase4active not recruitingnot on this mapstarted 2025, after this paper: background citation

Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias

TypeinterventionalSponsorVivek ReddyRan2025 to 2027Enrolled275ConditionsPersistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Long-standing Persistent Atrial FibrillationArmsFarapulse Catheter System, Low-dose Colchicine
NCT07021313 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation

TypeinterventionalSponsorR&D CardiologieRan2025 to 2028Enrolled378ConditionsAtrial FibrillationArmsPulmonary vein isolation by percutaneous endocardial catheter ablation using the FARAPULSE pulsed high voltage electrical field system in patients with atrial fibrillation, Pulmonary vein isolation by percutaneous endocardial catheter ablation using a pentaspline pulsed high voltage electrical field system in patients with atrial fibrillation
3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 8 syntheses or guidelines pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Pulsed field ablation for the interventional treatment of atrial fibrillation: a scientific statement of the European Heart Rhythm Association of the European Society of Cardiology, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Multielectrode catheter-based pulsed electric field vs. cryoballoon for atrial fibrillation ablation: a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Pooled it
  7. Pooled it
  8. Same-day discharge vs. overnight stay following catheter ablation for atrial fibrillation: a comprehensive review and meta-analysis by the European Heart Rhythm Association Health Economics Committee.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Pooled it
  9. Pulmonary vein isolation durability in a randomized trial comparing fluoroscopy-only vs. electroanatomic mapping strategies for pulmonary vein isolation with balloon-in-basket pulsed-field ablation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Trial
  10. Trial
  11. Indirect treatment comparison of two pulsed field ablation systems for the treatment of persistent atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Trial
  12. Trial
  13. Wide-Antral pulmonary vein isolation in patients undergoing atrial fibrillation ablation with a Single-Shot technique: rationale and design of the WIDER-PVI trial.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Trial
  14. Safety and effectiveness of the first balloon-in-basket pulsed field ablation system for the treatment of atrial fibrillation: VOLT CE Mark Study 6-month results.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  15. First-in-human trial of atrial fibrillation ablation using real-time tissue optical assessment to predict pulsed field lesion durability.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  16. Trial
  17. Efficacy and safety of a novel hexaspline pulsed field ablation system in patients with paroxysmal atrial fibrillation: the PLEASE-AF study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  18. Venous vascular closure system vs. figure-of-eight suture following atrial fibrillation ablation: the STYLE-AF Study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  19. Initial clinical experience with the balloon-in-basket pulsed field ablation system: acute results of the VOLT CE mark feasibility study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  20. Trial

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 6 countries.

Boris SchmidtCardioangiologisches Centrum Bethanien, Wilhelm-Epstein Str. 4, 60431 Frankfurt, Germany.ORCID 0000-0001-5347-9906
Stefano BordignonCardioangiologisches Centrum Bethanien, Wilhelm-Epstein Str. 4, 60431 Frankfurt, Germany.ORCID 0000-0002-0282-4658
Kars NevenDepartment of Electrophysiology, Alfried Krupp Hospital, Essen, Germany.ORCID 0000-0002-2075-8113
Tobias ReichlinInselspital-Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0002-7197-8415
Yuri BlaauwDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Jim HansenArrhythmia Unit, Department of Cardiology, Gentofte Hospital, Copenhagen, Denmark.ORCID 0000-0001-6600-9006
Raquel AdelinoHeart Rhythm Department, Clinique Pasteur, Toulouse, France.ORCID 0000-0002-8843-9370
Alexandre OussHeart Center Catharina Hospital, Eindhoven, The Netherlands.ORCID 0000-0001-7405-822X
Anna FütingDepartment of Electrophysiology, Alfried Krupp Hospital, Essen, Germany.ORCID 0000-0003-2116-1690
Laurent RotenInselspital-Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0002-0827-1329
Bart A MulderDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-4411-3918
Martin H RuwaldArrhythmia Unit, Department of Cardiology, Gentofte Hospital, Copenhagen, Denmark.ORCID 0000-0002-1541-309X
Roberto MenéHeart Rhythm Department, Clinique Pasteur, Toulouse, France.ORCID 0000-0003-1671-1977
Pepijn van der VoortHeart Center Catharina Hospital, Eindhoven, The Netherlands.ORCID 0000-0002-0927-3406
Nico ReinschDepartment of Electrophysiology, Alfried Krupp Hospital, Essen, Germany.ORCID 0000-0001-7385-2691
Thomas KuefferInselspital-Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0003-3553-4945
Serge BovedaHeart Rhythm Department, Clinique Pasteur, Toulouse, France.ORCID 0000-0002-1280-7042
Elizabeth M AlbrechtBoston Scientific Corporation, St. Paul, MN, USA.
Christopher W SchneiderBoston Scientific Corporation, St. Paul, MN, USA.ORCID 0009-0005-9675-8258
Kyoung Ryul Julian ChunCardioangiologisches Centrum Bethanien, Wilhelm-Epstein Str. 4, 60431 Frankfurt, Germany.ORCID 0000-0002-2355-6015
Clinique Pasteur · FRUniversity of Bern · CHWitten/Herdecke University · DEBoston Scientific (United States) · USCardiovascular Center Bethanien · DEGentofte Hospital · DKRadboud University Nijmegen · NLUniversity Medical Center Groningen · NLGoethe University Frankfurt · DE

Funding

Boston Scientific
6 · The paper itself

Abstract

aimsPulsed field ablation (PFA) is a new, non-thermal ablation modality for pulmonary vein (PV) isolation in patients with atrial fibrillation (AF). The multi-centre EUropean Real World Outcomes with Pulsed Field AblatiOn in Patients with Symptomatic AtRIAl Fibrillation (EU-PORIA) registry sought to determine the safety, efficacy, and learning curve characteristics for the pentaspline, multi-electrode PFA catheter. METHODS AND

resultsAll-comer AF patients from seven high-volume centres were consecutively enrolled. Procedural and follow-up data were collected. Learning curve effects were analysed by operator ablation experience and primary ablation modality. In total, 1233 patients (61% male, mean age 66 ± 11years, 60% paroxysmal AF) were treated by 42 operators. In 169 patients (14%), additional lesions outside the PVs were performed, most commonly at the posterior wall (n = 127). Median procedure and fluoroscopy times were 58 (interquartile range: 40-87) and 14 (9-21) min, respectively, with no differences due to operator experience. Major complications occurred in 21/1233 procedures (1.7%) including pericardial tamponade (14; 1.1%) and transient ischaemic attack or stroke (n = 7; 0.6%), of which one was fatal. Prior cryoballoon users had less complication. At a median follow-up of 365 (323-386) days, the Kaplan-Meier estimate of arrhythmia-free survival was 74% (80% for paroxysmal and 66% for persistent AF). Freedom from arrhythmia was not influenced by operator experience. In 149 (12%) patients, a repeat procedure was performed due to AF recurrence and 418/584 (72%) PVs were durably isolated.

conclusionThe EU-PORIA registry demonstrates a high single-procedure success rate with an excellent safety profile and short procedure times in a real-world, all-comer AF patient population.

Indexed as

Atrial FibrillationCatheter AblationPoriaPulmonary VeinsAgedFemaleFluoroscopyHumansMaleMiddle AgedRecurrenceTreatment OutcomeAblationAtrial fibrillationElectroporationPulsed field ablation

Identifiers

PMID37379528
PMCPMC10320231
OpenAlexW4382502299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.